Redeye raises its forecasts and Base Case slightly following a Q2 report beating our forecasts somewhat. The strong ARR growth is the quarter’s highlight, implying a larger contribution from recent price increases than anticipated.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases